As you might recall from previous blog posts, more and more states are requiring cannabis companies to enter into labor peace agreements with unions in order to obtain their licenses, but could that soon go up in smoke? The National Right to Work Legal Defense Foundation (“NRTWF”) asked the National Labor Relations Board (“NLRB”) for help when New Jersey took one toke over the line by requiring cannabis companies to not only enter into…

Welcome back to The Week in Weed, your Friday look at what’s happening in the world of legalized marijuana. Let’s start off with the DEA.  On Monday, they released a proposed rule to expand marijuana research.  For the first time, more than one institution would be permitted to register with the agency and grow cannabis.  The comment period runs until May 22, 2020, and then final rules will appear – no timeline for those.  So…

In response to the drastic economic impact COVID-19 has had on small businesses in recent weeks, President Trump announced that the Small Business Administration (SBA) was authorized to provide $50 billion in low-interest loans – more than double the amount of loans provided by the SBA in 2019 – to keep them operating during the pandemic. After the announcement, the SBA established a disaster assistance loan program for small businesses, which could potentially provide up…

With the spread of COVID-19 fears, states and cities nationwide are in the process of issuing a variety of executive orders and other ordinances shutting down businesses that are considered “non-essential.”  However, what is considered “essential” differs by state and locality.  Across the board, these laws have included healthcare services as “essential.” The question many have is whether marijuana dispensaries will fall into this “essential” category. New York: At the time of publication, Governor Cuomo’s…

CBD continues to flourish in the markets despite lack of federal regulations, and we’ve identified some significant events that indicate there’s no sign it’s stopping. Topical CBD Pain-Relief Receives FDA Product Listing Certification Elixicure, an over-the-counter (OTC) CBD-infused topical pain-relief cream marketed for treating inflammation, aches, and pains, has received product listing certification from the Food & Drug Administration (FDA).  This certification is the first of its kind for a topical OTC drug containing CBD. …